10/20/2026
Yesterday we marked the launch of a new research partnership with Fundación Romero to advance the search for a tuberculosis vaccine that can protect people in Peru and around the world.
Based in the Bryson Lab at the Ragon Institute of Mass General Brigham, MIT, and Harvard, the work will incorporate the genetic diversity of Peru’s population and build close collaboration with researchers in Peru. Grounding the science in that diversity strengthens the prospects for a vaccine that reaches many different communities.
TB remains one of the world’s deadliest infectious diseases. This long-term effort brings together partners across health, academia, and the organizations working to change that.
Our thanks to Fundación Romero for joining us in this work.